Search - tctmd.com

Displaying 121 - 140 of 581

Sort: Relevancy | Date

Presentation NY Valves 2025

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Presenter: Fabio Sandoli de Brito

June 25, 2025

Presentation NY Valves 2025

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

Presenter: Pradeep K. Yadav

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Lifetime Management Considerations

Presenter: Sachin S. Goel

June 25, 2025

Presentation NY Valves 2025

Integrating AI workflow into Heart Team & Reimbursement workflow.

Presenter: Pradeep K. Yadav

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Importance of Preserving Coronary Access after TAVI

Presenter: Laura Flannery

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Optimal Implantation Technique

Presenter: Saurabh Sanon

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Importance of PPM

Presenter: Rishi Puri

June 25, 2025

Presentation NY Valves 2025

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

Presenter: Santiago Garcia

June 25, 2025

Presentation NY Valves 2025

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Presenter: Shinichi Fukuhara

June 25, 2025

Presentation NY Valves 2025

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Presenter: Sammy Elmariah

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

Can We Solve the Durability Issue? Insights Into New Valve Designs

Presenter: Tamim M. Nazif

June 25, 2025

Presentation NY Valves 2025

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Presenter: Mayra Guerrero

June 25, 2025

Presentation NY Valves 2025

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

Presenter: Christine J. Chung

June 25, 2025

Presentation NY Valves 2025

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Presenter: Isaac George

June 25, 2025

Presentation NY Valves 2025

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

CT Reduces In-Hospital Complications in SAVR

Presenter: Liliane Zillner

June 25, 2025

Presentation NY Valves 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Raj Makkar

June 25, 2025

Presentation NY Valves 2025

Perspectives From TAVR UNLOAD

Presenter: Nicolas M. Van Mieghem

June 25, 2025

Advertisement

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

Heart Team Discussion: Lifetime Management Considerations

Integrating AI workflow into Heart Team & Reimbursement workflow.

Heart Team Discussion: Importance of Preserving Coronary Access after TAVI

Heart Team Discussion: Optimal Implantation Technique

Heart Team Discussion: Importance of PPM

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Case Resolution

Can We Solve the Durability Issue? Insights Into New Valve Designs

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

CT Reduces In-Hospital Complications in SAVR

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives From TAVR UNLOAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content